TORNTPHARM

What Torrent Pharmaceuticals promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 18 tracked 1 delivered 5 missed 12 open
  • India Field Force (MRs) delivered said Q2 FY25 Promised: Add 100-200 by end of FY25; later revised to 7,000 by end of FY26 Q1 FY27: Promise achieved in FY26. This metric is now superseded by the combined entity's field force tracking post-JB merger.
  • Net Debt missed said Q2 FY25 Promised: Net Cash by FY26 Q1 FY27: Original target remains missed. However, Net Debt/EBITDA improved to 2.07x from 2.3x in the previous quarter, showing progress towards the revised deleveraging goal.
  • Cost Synergies revised up said Q3 FY26 Promised: ₹400-450 crores over 2-3 years Q1 FY27: Synergies are being realized 'sooner than expected'. The year 1 target of ~₹90 cr is now guided to be 'definitely... above 100' cr. The pace of realization has been revised up.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 18 tracked commitments for Torrent Pharmaceuticals — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens